Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1995-7-6
|
pubmed:abstractText |
In this review we summarize recent work on the molecular basis of apoptosis in the murine B cell lymphoma WEHI-231. WEHI-231 cells undergo apoptosis in response to antigen receptor cross-linking with anti-Ig reagents. Death is specifically triggered via surface IgM (sIgM); cross-linking sIgD, Ia or FcR has no effect. Apoptosis is preceded by growth arrest in the G0/G1 phase of the cell cycle and may not occur in all currently available WEHI-231 sublines. The continuous passage of WEHI-231 cells in different laboratories has yielded variants that differ greatly in their response to anti-Ig treatment because apoptotic cells tend to be negatively selected in culture. Resistant and susceptible variants undergo growth arrest in response to anti-Ig but only susceptible cells go on to die by apoptosis. Cells resistant to anti-Ig have intact apoptotic machinery as indicated by their susceptibility to dexamethasone, irradiation and other treatments. However, anti-Ig-resistant cells are also resistant to apoptosis induced by the immunosuppressants cyclosporin A, FK-506 and rapamycin. We discuss the experimental evidence indicating that the apoptotic machinery in WEHI-231 cells is pre-activated but under constant negative regulation by short-lived protein inhibitors. Inhibition is removed by a mediator released in response to anti-Ig treatment in susceptible sublines. The mediator of death is the sphingosine derivative, ceramide, presumably produced by membrane sphingomyelinases activated by anti-Ig. A hypothetical model on how ceramide kills WEHI-231 is presented.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0818-9641
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
73
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
8-16
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7768548-Animals,
pubmed-meshheading:7768548-Apoptosis,
pubmed-meshheading:7768548-Autoantibodies,
pubmed-meshheading:7768548-B-Lymphocytes,
pubmed-meshheading:7768548-Ceramides,
pubmed-meshheading:7768548-Lipopolysaccharides,
pubmed-meshheading:7768548-Mice,
pubmed-meshheading:7768548-Models, Immunological,
pubmed-meshheading:7768548-T-Lymphocytes, Helper-Inducer,
pubmed-meshheading:7768548-Tumor Cells, Cultured
|
pubmed:year |
1995
|
pubmed:articleTitle |
Apoptosis in B lymphocytes: the WEHI-231 perspective.
|
pubmed:affiliation |
Department of Pathology and Cancer Research Center, University of Chicago, IL 60637, USA.
|
pubmed:publicationType |
Journal Article,
Review
|